1. Home
  2. FLGT vs NXP Comparison

FLGT vs NXP Comparison

Compare FLGT & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$14.77

Market Cap

867.4M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Select Tax Free Income Portfolio

NXP

Nuveen Select Tax Free Income Portfolio

HOLD

Current Price

$14.37

Market Cap

728.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGT
NXP
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
867.4M
728.1M
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
FLGT
NXP
Price
$14.77
$14.37
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$28.33
N/A
AVG Volume (30 Days)
607.9K
118.7K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,730,000.00
N/A
Revenue This Year
$10.66
N/A
Revenue Next Year
$12.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.46
$13.30
52 Week High
$31.04
$14.65

Technical Indicators

Market Signals
Indicator
FLGT
NXP
Relative Strength Index (RSI) 25.46 48.96
Support Level $13.46 $14.35
Resistance Level $22.97 $14.63
Average True Range (ATR) 0.96 0.10
MACD -0.14 -0.02
Stochastic Oscillator 11.84 34.53

Price Performance

Historical Comparison
FLGT
NXP

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About NXP Nuveen Select Tax Free Income Portfolio

Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.

Share on Social Networks: